Treating obese patients with poorly controlled diabetes: Confessions of an insulin therapist

Diabetes/Metabolism Research and Reviews

Volumn 15, Issue 3, 1999, Pages 219-225

  Kerr, David ^a   Cavan, David ^a  

^a ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

Author keywords

Diabetes; Education; Exercise; Insulin; Obesity; Weight

Indexed keywords

DARGLITAZONE; DEXFENFLURAMINE; FLUOXETINE; INSULIN; METFORMIN; ROSIGLITAZONE; SIBUTRAMINE; TETRAHYDROLIPSTATIN; THIAZOLIDINE DERIVATIVE; TROGLITAZONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIABETES CONTROL; DIABETES MELLITUS; DIET; FEMALE; HUMAN; METABOLISM; OBESITY; PATIENT EDUCATION; PRIORITY JOURNAL; WEIGHT GAIN;

DIABETES MELLITUS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LIFE STYLE; OBESITY;

EID: 0032773549     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-7560(199905/06)15:3<219::AID-DMRR32>3.0.CO;2-V     Document Type: Article

References (34)

1. Royal College of Physicians. Clinical Management of Overweight and Obese Patients. London: Royal College of Physicians, 1998.
2. Prescott-Clark P. (ed). Health Survey for England 1996. London: HMSO, 1998.
3. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood glucose control with metformin on complications in overweight patients with Type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854-865.
4. UK Prospective Diabetes Study Group (UKPDS). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
5. Everett J, Kerr D. Nurse-led management of newly diagnosed Type 2 diabetes. J Diabetes Nursing 1998; 2: 12-21.
6. Wadden TA. Treatment of obesity by moderate and severe caloric restriction. Results of clinical research trials. Ann Intern Med 1993; 119: 688-693.
7. Brown SA, Upchurch S, Anding R, Winter M, Ramirez G. Promoting weight loss in type 2 diabetes. Diabetes Care 1996; 19: 613-624.
8. Lean ME. Obesity-what are the current treatment options? Exp Clin Endocrinol Diabetes 1998; 106 (Suppl): 22-26.
9. Wing R. Use of very-low-calorie diets in treatment of obese persons with non-insulin-dependent diabetes mellitus. J Am Dietetic Assoc 1995; 95: 569-572.
10. Wing RR, Marcus MD, Salata R, Epstein IH, Miaskiewicz S, Blair EH. Effects of a very-low-calorie diet on long-term glycemic onctrol in obese Type 2 diabetic subjects. Arch Intern Med 1994; 151: 1334-1340.
11. Paisey RB, Harvey P, Rice S, et al. An intensive weight loss programme in established type 2 diabetes and controls: effects on weight and atherosclerosis risk factors at 1 year. Diabet Med 1998; 15: 73-79.
12. Burley VJ, Krietzman SN, Hill AJ, Blundell JE. Across-the-day monitoring of mood and energy intake before, during and after very-low-calorie diet. Am J Clin Nutr 1992; 56: 277S-278S.
13. Drenick EJ, Alvarez LA, Tamasi CC, Bruckman AS. Resistance to symptomatic insulin reactions after fasting. J Clin Invest 1972; 51: 2757-2762.
14. Summerbell CD, Watts C, Higgins JPT, Garrow JS. Randomised controlled trial of novel, simple and well supervised weight reducing diets in outpatients. BMJ 1998; 317: 1487-1489.
15. Weinstock RS, Dai H, Wadden TA. Diet and exercise in the treatment of obesity: effects of 3 interventions on insulin resistance. Arch Intern Med 1998; 158: 2477-2483.
16. Guichard-Rode S, Charrie A, Penet D, Teboul F, Thivolet C. Massive weight loss does not restore normal insulin secretory pulses in obese patients with Type 2 (non-insulin-dependent) diabetes mellitus. Diabetes Metab 1997; 23: 506-510.
17. Sinha A, Formica C, Tsalamandris C, et al. Effects of insulin on body composition in patients with insulin-dependent and non-insulin-dependent diabetes. Diabet Med 1996; 13: 40-46.
18. Yki-Jarvinen H, Ryysy L, Kujansuu E, et al. Effect of obesity on the response to insulin therapy in non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997; 82: 4037-4043.
19. Campbell PJ, Carlson MG. Impact of obesity on insulin action in NIDDM. Diabetes 1993; 42: 405-410.
20. DeFronzo RA, Goodman AM, The Multicenter Metformin Study Group. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. N Eng J Med 1995; 333: 541-549.
21. Lee A, Morley JE. Metformin decreases food consumption and induces weight loss in subjects with obesity with Type 2 (non-insulin-dependent) diabetes. Obes Res 1998; 6: 47-53.
22. Relimpoi F, Pumar A, Losada F, Mangas MA, Acosta D, Astorga R. Adding metformin versus insulin dose increase in insulin-treated but poorly controlled Type 2 diabetes: an open-label randomised trial. Diabet Med 1998; 15: 997-1002.
23. Ronnemaa T, Viikari J. reducing snacks when switching from conventional soluble to Lispro insulin treatment: effects on glycaemic control and hypoglycaemia. Diabet Med 1998; 15: 601-607.
24. Anderson JH, Brunelle RL, Koivisto VA, et al. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group. Diabetes 1997; 46: 265-270.
25. Maheux P, Ducross F, Bourque J, Garon J, Chiasson JL. Fluoxetine improves insulin sensitivity in obese patients with non-insulin-dependent diabetes mellitus independently of weight loss. Int J Obes Metab Disord 1997; 21: 97-102.
26. McNeely W, Goa KL. Sibutramine. A review of its contribution to the management of obesity. Drugs 1998; 56: 1093-1124.
27. Schwartz S, Raskin P, Fonseca V, Graveline JF. Effect of troglitazone in insulin-treated patients with Type 2 diabetes. N Eng J Med 1998; 338: 861-866.
28. Hollander PA, Elbein SC, Hirsch IB, et al. Role of Orlistat in the treatment of obese patients with type 2 diabetes. Diabetes Care 1998; 21: 1288-1294.
29. Sjostrom L, Rissanen A, Anderson T, et al. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet 1998; 352: 160-161.
30. Muzzin P, Eisensmith RC, Copeland KC, Woo SL. Correction of obesity and diabetes in genetically obese mice by leptin therapy. Proc Natl Acad Sci U S A 1996; 93: 14804-14808.
31. Pi-Sunyer FX, Laferrere B, Aronne LJ, Bray GA. Therapeutic controversy: obesity - a modern day epidemic. J Clin Endocrinol Metab 1999; 84: 3-12.
32. Amgen press release. 1 Amgen Center Drive, Thousand Oaks, CA 91320, 1997.
33. Groves JE. Taking care of the hateful patient. N Eng J Med 1978; 298: 883-887.
34. O'Dowd TC. Five years of heartsink patients in general practice. BMJ 1998; 297: 528-530.